Application of ewe excrement flora marker in preparation of ewe early pregnancy in-vitro diagnostic reagent

By analyzing the microbial composition of ewe feces and identifying marker groups related to pregnancy and empty pregnancy, the problem of poor accuracy in the early stage of ewe pregnancy diagnosis is solved, non-invasive and accurate early stage pregnancy diagnosis is achieved, and the efficiency of reproductive management is improved.

CN118932091APending Publication Date: 2024-11-12LANZHOU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411015867.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing ewe pregnancy diagnosis technology is poor in the early diagnosis, and the traditional methods are highly invasive, making it difficult to efficiently shorten the lambing interval and improve reproductive efficiency.

Method used

By studying the changes in the microbial composition of ewe feces, identifying microbial markers related to pregnancy and empty pregnancy, PCR extraction and 16S rDNA sequencing methods were used to measure the relative abundance of microbial flora in feces, and preparing in vitro diagnostic reagents for early pregnancy.

Benefits of technology

It provides a non-invasive and accurate diagnosis method for early pregnancy, improves the efficiency of ewe breeding management, and promotes the development of early pregnancy diagnosis technology for ewes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention provides application of an ewe excrement flora marker in preparation of an ewe early pregnancy in-vitro diagnostic reagent. The excrement marker is an excrement microbial flora; the in-vitro diagnosis method comprises the following steps: providing an ewe manure test sample; measuring the relative abundance of the microbial flora in the sample; 0.05) of the relative abundance of the pregnancy marker flora Actinobacteria in a non-pregnancy control reference sample is determined, if the relative abundance of the pregnancy marker flora Actinobacteria in the non-pregnancy control reference sample is significantly increased, the ewe is in an early pregnancy stage; or determining whether the relative abundance of the non-pregnant marker flora Firmicite, Bacteroido, Bacteroida and Clostridia in the sample is remarkably increased (plt; 0.05) relative to the pregnancy control reference sample, and if so, determining that the ewe is in the non-pregnancy stage. The flora can be used for preparing an ewe early pregnancy in-vitro diagnostic reagent. Therefore, the invention provides a new early pregnancy diagnosis method, and provides a new direction for promoting the development of an early pregnancy diagnosis technology for ewe pregnancy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to the screening of a fecal marker that can be used for marking ewe pregnancy. The marker can be used to prepare an in vitro diagnostic reagent for early ewe pregnancy. Background Art

[0002] Sheep farming is a traditional advantageous animal husbandry industry in Northwest my country, and it is also an important breakthrough in promoting the transformation and leapfrog development of agriculture in the region. With the implementation of the national ecological protection strategy, the space for grazing sheep is getting smaller and smaller. Only by increasing the number of sheep raised in sheds and improving the production efficiency of sheep raised in sheds can the market demand for mutton be met. Therefore, intensive, large-scale, environmentally friendly and sustainable development are the future development directions of animal husbandry. Fertility is one of the important economic indicators of intensive and large-scale sheep production, and the increase in feed costs and the decline in fertility have caused low sheep farming efficiency, which is one of the major problems facing the sheep farming industry in our province. Improving the fertility of the flock is helpful to improve production efficiency. Among the costs of raising sheep in sheds, the cost of raising ewes accounts for more than 60% of the total cost of raising sheep. Improving the reproductive performance of ewes significantly improves the economic benefits of producers. Therefore, in the production management of large-scale sheep farming, early pregnancy diagnosis is one of the important means to shorten the lambing interval and improve the reproductive efficiency of ewes.

[0003] Traditional diagnosis of ewe pregnancy mainly relies on: (1) external observation method: after pregnancy, the ewe's body condition improves, fatness recovers, and the coat becomes shiny; the mucous membranes of the vagina and vulva become pale, the vaginal wall is dry, and the vulva is tightly closed. However, this method is mainly used in the middle and late stages of pregnancy, and its accuracy is poor when diagnosing in early pregnancy. (3) Reproductive hormone changes: after pregnancy, the corpus luteum on the ovary begins to move, and serum hormones change. Since many hormones are released in a pulsed manner, it is difficult to make an accurate judgment with a single measurement, and this method is an invasive test. (3) Ultrasonic diagnosis method: using the principle of ultrasound reflection in the ewe's body to perform imaging, the development of the uterus, fetus, and ovaries can be observed to determine whether the ewe is pregnant. However, this method requires a high level of technical skills, and a high accuracy rate can only be achieved after 35 days of pregnancy, otherwise misdiagnosis or missed diagnosis may occur.

[0004] Intestinal microorganisms play a vital role in host metabolism, immunity and endocrine, and are affected by environmental, dietary, hormone and other factors and change. After the female animal becomes pregnant, the composition and function of the intestinal microbial community will also be affected due to changes in hormone levels and metabolic states in the body. Therefore, the present invention aims to further analyze the diversity, abundance and key flora of the intestinal microbiome by studying the changes in fecal microbial composition of ewes during pregnancy and empty-pregnancy periods, reveal the characteristics of the microbiome flora associated with pregnancy, and thus provide a non-invasive and highly feasible early pregnancy detection method, improve the breeding management and breeding efficiency of mutton sheep, and achieve a higher level of economic benefits. Summary of the invention

[0005] The purpose of the present invention is to solve the above-mentioned technical problems existing in the existing ewe pregnancy diagnosis technology, and to provide a fecal marker that can be used for the diagnosis of early pregnancy in ewes. The fecal marker is a specific microbial flora and can be used to prepare an in vitro diagnostic reagent for early pregnancy in ewes.

[0006] To achieve its purpose, the present invention adopts the following technical solutions: The present invention provides a fecal microbial flora that can be used for early pregnancy diagnosis of ewes. The microbial flora is divided into a pregnancy marker flora and a pregnancy marker flora, and can be used to prepare an in vitro diagnostic reagent for early pregnancy in ewes. The in vitro diagnostic method comprises: Provide fecal test samples from ewes; measuring the relative abundance of microbial flora in the sample; Determine whether the relative abundance of the pregnancy marker flora in the sample is significantly increased (p<0.05) relative to the non-pregnant control reference sample. If so, the ewe is in the early pregnancy stage; the pregnancy marker flora is Actinobacteriota ; Or: determine whether the relative abundance of the empty marker flora in the sample is significantly increased (p<0.05) relative to the pregnant control reference sample, and if so, the ewe is in the non-pregnant stage; the empty marker flora includes Firmicutes, Bacteroidota, Bacteroidia and Clostridia .

[0007] As a further preferred embodiment of the technical solution of the present invention, the ewe feces test sample comes from an early pregnant ewe.

[0008] Preferably, the early pregnancy refers to 21 days after the ewe is mated.

[0009] Preferably, the ewe feces test sample is ewe rectal feces.

[0010] Preferably, the ewe is a sheep.

[0011] Preferably, the stool marker detection method is PCR extraction and 16S rDNA sequencing method.

[0012] The beneficial effects of the present invention are: The present invention uses the significant changes in the microbial flora in the feces of early pregnant ewes compared to non-pregnant ewes as a basis for judging early pregnancy in ewes. Among them, the marker flora of pregnant ewes is Actinobacteriota The characteristic flora of empty-breasted ewes includes Firmicutes, Bacteroidota, Bacteroidia and Clostridia The bacterial flora can be used to prepare an in vitro diagnostic reagent for early pregnancy in ewes. Therefore, the invention provides a new method for diagnosing early pregnancy, and provides a new direction for promoting the development of early pregnancy diagnosis technology in ewes. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 This is the ASV cluster analysis diagram of fecal microorganisms in pregnant group (P) and non-pregnant group (NP) of ewes; Figure 2 The differential bacterial flora analysis of fecal microbial phylum level between pregnant (P) and non-pregnant (NP) ewes; Figure 3 The difference in bacterial flora at the fecal microbial class level between pregnant (P) and non-pregnant (NP) ewes was analyzed; Figure 4 This is the LEfse analysis chart of fecal microorganisms of pregnant (P) and non-pregnant (NP) ewes. DETAILED DESCRIPTION

[0014] The present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention, and those skilled in the art may make some non-essential improvements and adjustments to the present application based on the above application content.

[0015] 1. Materials The methods used in this example are conventional methods known to those skilled in the art unless otherwise specified, and the reagents and other materials used are commercially available products unless otherwise specified.

[0016] Experimental animals: The experimental animals used in this embodiment are Tianhua sheep.

[0017] 2. Methods 2.1 Fecal sample collection Fecal samples were collected 21 days after mating of the ewes. During the collection, the sampling personnel wore disposable sterile gloves and gently stirred with their fingers to help the sheep feces to be discharged from the rectum. After collection, the fresh feces were quickly transferred to a sterile 5 mL centrifuge tube and stored at -80℃ for later use.

[0018] 2.2 Ewe pregnancy test The ewes were examined by B-ultrasound examination 50 days after mating, and then the fecal samples were divided into pregnant (P, n=24) and non-pregnant (NP, n=15) groups according to the results of B-ultrasound examination.

[0019] 2.3 Extraction of fecal genomic DNA Fecal genomic DNA was extracted using the magnetic bead method and fecal genomic DNA kit. The specific steps are as follows: (1) Add 0.25-0.5 g of fecal sample to a 2 mL centrifuge tube, add 500 μL buffer SA, 100 μL buffer SC, 0.25 g of grinding beads and 10 μL RNase A, vortex and mix well, then add lysis buffer preheated at 70°C and react for 15 min. Centrifuge at 12,000 rpm for 1 min, transfer the supernatant to a new centrifuge tube for subsequent experiments.

[0020] (2) Add 200 μL of buffer SH, mix well, vortex for 5 seconds, and incubate at 4°C for 10 min.

[0021] (3) Centrifuge at 12,000 rpm for 3 min, transfer the supernatant to a new centrifuge tube, add 500 μL of buffer GFA, and invert to mix.

[0022] (4) Add 10 μL of magnetic bead suspension G and vortex to mix for 5 min.

[0023] (5) Place the centrifuge tube on the magnetic rack and let it stand for 30 seconds. After the magnetic beads are completely adsorbed, remove the liquid.

[0024] (6) Remove the centrifuge tube from the magnetic rack, add 700 μL of deproteinized solution RD, and vortex to mix for 5 min.

[0025] (7) Place the centrifuge tube on the magnetic rack and let it stand for 30 seconds. After the magnetic beads are completely adsorbed, remove the liquid.

[0026] (8) Remove the centrifuge tube from the magnetic rack, add 700 μL of rinse solution PWD, and shake to mix for 3 min.

[0027] (9) Place the centrifuge tube on the magnetic rack and let it stand for 30 seconds. After the magnetic beads are completely adsorbed, remove the liquid.

[0028] (10) Repeat step 8 (8) and step (9) once.

[0029] (11) Place the centrifuge tube on a magnetic rack and dry it at room temperature for 5-10 min.

[0030] (12) Remove the centrifuge tube from the magnetic rack, add 50-100 μL of elution buffer TB, vortex to mix, place at 56°C, and incubate for 5 min. During this time, vortex to mix 3 times, 3-5 times each time.

[0031] (13) Place the centrifuge tube on a magnetic rack and let it stand for 2 min. After the magnetic beads are completely adsorbed, transfer the DNA solution to a new centrifuge tube and store at -20°C until tested.

[0032] 2.4 Acquisition, mixing and purification of PCR products Primer corresponding region: 16SV4 region primers 515F and 806R (515F is 5′-GTGCCAGCMGCCGCGGTAA-3′, 806R is 5′-GGACTACHVGGTWTCTAAT-3′). All PCR mixtures were added with 15 µL Phusion® High-Fidelity PCR Master Mix, 0.2 μL primers and 10 ng DNA template, and the first denaturation was performed at 98°C for 1 min, followed by 30 cycles at 98°C (10 s), 50°C (30 s) and 72°C (30 s), and finally kept at 72°C for 5 min.

[0033] Use 2% agarose gel electrophoresis to detect the PCR product, and the qualified PCR product is purified by magnetic beads. After enzyme-labeled quantification, equal amounts of samples are mixed according to the concentration of PCR products, and after sufficient mixing, they are detected by 2% agarose gel electrophoresis. The product of the target band is recovered using a DNA purification recovery kit.

[0034] 2.2.7 Library construction and sequencing The library was constructed using the NEB Next® Ultra™ II FS DNA PCR-free Library Prep Kit. After the constructed library was qualified by Qubit and qPCR quantification, it was sequenced on the NovaSeq6000 using PE 250.

[0035] 2.5 Microbial data analysis According to the Barcode sequence and PCR amplification primer sequence, the data of each sample was split from the offline data. After the Barcode and primer sequences were cut off, the reads of each sample were spliced ​​using FLASH (Version 1.2.11). The spliced ​​sequence was the original Tags data (Raw Tags). The spliced ​​RawTags were strictly filtered using fastp software (Version 0.23.1) to obtain high-quality Tags data (Clean Tags). The obtained Clean Tags sequence was compared with the species annotation database (Silva database https: / / www.arb-silva.de / for 16S) to detect chimera sequences, and finally the chimera sequences were removed to obtain the final effective data (EffectiveTags). Then, the above-obtained Effective Tags were denoised using the DADA2 module in the QIIME2 (VersionQIIME2-202006) software to obtain the final ASVs (Amplicon Sequence Variants) and feature table. Finally, QIIME2 software was used to annotate species and analyze the abundance and community diversity of ASVs. Figure 1 As shown, there were 3053 ASVs unique to the empty group, 7397 ASVs unique to the pregnant group, and 5701 ASVs shared by the two groups.

[0036] 2.6 Analysis of microbial community differences Analysis of differential bacterial flora at the phylum level revealed that Figure 2 As shown, pregnant ewes Proteobacteria, Actinobacteriota, Acidobacteriota, Chloroflexi, Myxococcota, Gemmatimonadota and Planctomycetota The relative abundance of Firmicutes and Bacteroidota The relative abundance of ewes was significantly lower than that of empty-stomach ewes (P < 0.05).

[0037] Analysis of differential bacterial flora at the class level revealed that Figure 3 As shown, pregnant ewes Actinobacteria, Alphaproteobacteria, Thermoleophilia, Vicinamibacteria 、KD4-96 、 Gemmatimonadetes, Acidimicrobiia, Rubrobacteria, Chloroflexia 、MB-A2-108、 Planctomycetes, Polyangia and Blastocatellia The relative abundance of bacterial genera was significantly higher in empty-stomach ewes (P <0.05). Clostridia and Bacteroidia The relative abundance of ewes was significantly lower than that of empty-stomach ewes (P < 0.05).

[0038] 2.7 LEfse analysis LEfse uses linear discriminant analysis (LDA) to assess the influence of each species abundance on the difference effect, and then identify the communities or species that make significant differences in sample partitioning (the screening threshold is P < 0.05, LDA score > 4). The results are as follows Figure 4 , one bacterial group was significantly enriched in pregnant ewes, and four bacterial groups were significantly enriched in empty ewes. Therefore, the characteristic bacterial group of Tianhua mutton sheep pregnant ewes is Actinobacteriota The characteristic flora of empty-stomach ewes is Firmicutes, Bacteroidota, Bacteroidia, and Clostridia This result corresponds to the above-mentioned differential flora results.

[0039] The embodiments described above are only descriptions of the preferred methods of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the scope of protection determined by the claims of the present invention.

Claims

1. Application of fecal flora markers of ewes in the preparation of in vitro diagnostic reagents for early pregnancy in ewes, It is characterized in that The fecal marker is a fecal microbial flora, which is divided into a pregnancy marker flora and a pregnancy marker flora; the in vitro diagnostic method includes: Provide fecal test samples from ewes; measuring the relative abundance of microbial flora in the sample; Determine whether the relative abundance of the pregnancy marker flora in the sample is significantly increased (p<0.05) relative to the non-pregnant control reference sample. If so, the ewe is in the early pregnancy stage; the pregnancy marker flora is Actinobacteriota ; Or: determine whether the relative abundance of the empty marker flora in the sample is significantly increased (p<0.05) relative to the pregnant control reference sample, and if so, the ewe is in the non-pregnant stage; the empty marker flora includes Firmicutes, Bacteroidota, Bacteroidia and Clostridia .

2. Use of the ewe fecal flora marker according to claim 1 in the preparation of an in vitro diagnostic reagent for early pregnancy in ewes, It is characterized in that The ewe feces test sample is from an early pregnant ewe.

3. Use of the fecal flora marker of ewe as claimed in claim 2 in the preparation of an in vitro diagnostic reagent for early pregnancy in ewe, It is characterized in that The early pregnancy refers to 21 days after the ewe is bred.

4. Use of the ewe fecal marker according to claim 1 in the preparation of an in vitro diagnostic reagent for early pregnancy in ewes, It is characterized in that The ewe feces test sample is ewe rectal feces.

5. Use of the ewe fecal marker according to any one of claims 1 to 4 in the preparation of an in vitro diagnostic reagent for early pregnancy in ewes, It is characterized in that The ewe is a sheep.

6. Use of the ewe fecal marker according to any one of claims 1 to 4 in the preparation of an in vitro diagnostic reagent for early pregnancy in ewes, It is characterized in that The stool marker detection method is PCR and 16S rDNA sequencing method.